Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BACE

Beta-secretase 1 (BACE1), also known as beta-site amyloid precursor protein cleaving enzyme 1, beta-site APP cleaving enzyme 1, membrane-associated aspartic protease 2, memapsin-2, aspartyl protease 2, and ASP2, is an enzyme that in humans is encoded by the BACE1 gene. Expression of BACE1 is observed mainly in neurons.BACE1 is an aspartic-acid protease important in the formation of myelin sheaths in peripheral nerve cells: in mice the expression of BACE1 is high in the postnatal stages, when myelination occurs.

  • Phytic acid potassium
    T5075129832-03-7
    Phytic acid dipotassium salt is an endogenous metabolite that inhibits β-secretase 1 (BACE1).
    • $41
    In Stock
    Size
    QTY
  • SEW06622
    T83616261349-28-4
    SEW06622 is a potent inhibitor of acetylcholinesterase (AChE) and beta-secretase-1 (BACE-1) and is a potential candidate for the treatment of Alzheimer's disease.
    • $195
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • DSS30
    T61439883027-32-5In house
    DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).DSS30 can be used for the prevention and treatment of neurodegenerative diseases such as Alzheimer's disease.
    • $350
    In Stock
    Size
    QTY
  • BACE-IN-1 acetate
    T3161L
    BACE-IN-1 acetate (BACE-IN-1 acetate (350228-37-4,Free base)) has been used as β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE1) inhibitor in BACE1 inhibitor assay. β-Site amyloid precursor protein (APP) cleaving enzyme-1 (BACE1), an aspartic protease belongs to the protease family of enzymes comprises of six luminal cysteine residues. These residues help in the formation of three intermolecular disulfide bonds and N-linked glycosylation sites.
    • $148
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Sophoflavescenol
    TN2217216450-65-6
    Sophoflavescenol is a mixed inhibitor of PDE5 with a K(i) value of 0.005 microM. Sophoflavescenol has antioxidant, anti-inflammatory, and apoptotic effects , these effects might contribute to the antitumor activity without severe side effects. Sophoflaves
    • $657
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Putraflavone
    TN486523624-21-7
    Putraflavone possesses a good antioxidant activity via its DPPH free radical scavenging.
    • $1,960
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cassiaside
    TN147213709-03-0
    Cassiaside is a naphthyl ketone glycoside that inhibits BACE1 (IC50= 4.45 μM; Ki=9.85 μM).Cassiaside exhibits significant hepatoprotective effects against galactosamine injury and has potential anti-Alzheimer's disease (AD) activity.
    • $84
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Kushenol C
    TN439999119-73-0
    Kushenol C is a good 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenger, and it exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2). Kushenol C shows antimicrobial activity against Staphylococcus aureus and Streptococcus mutan
    • $1,329
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Scoulerine
    TN21906451-73-6
    Scoulerine is an inhibitor of ß-site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.
    • $127
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Bavachromene
    TN143441743-38-8
    Bavachromene exhibits a significant inhibitory effect on baculovirus-expressed BACE-1 in vitro.
    • $1,198
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Isorubrofusarin-6-O-β-gentiobioside
    TN1799200127-93-1
    Isorubrofusarin-6-O-β-gentiobioside is derived from from Cassia obtusifolia Linn seeds and shows promising inhibitory activity against AChE and BACE1.
    • $221
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Anatabine
    TN3410581-49-7
    Anatabine shows anti-inflammatory activity in vitro and in vivo, which is mediated in part via an inhibition of STAT3 phosphorylation.Anatabine has anti-Alzheimer's disease effects, it inhibits BACE-1 transcription and reduces BACE-1 protein levels in hum
    • $578
    Backorder
    Size
    QTY
  • AM-6494
    T102921874232-80-0
    AM-6494 is a potent and orally active BACE1 inhibitor (IC50: 0.4 nM) with in vivo selectivity over BACE2 (IC50: 18.6 nM).
    • $3,920
    Backorder
    Size
    QTY
  • BACE1-IN-1
    T104501310347-50-2
    BACE1-IN-1 is a high brain penetrant BACE1 inhibitor (IC50s: 32 and 47 nM for human BACE1 and BACE2).
    • $1,650
    Backorder
    Size
    QTY
  • Lanabecestat
    TQ02381383982-64-6
    Lanabecestat (AZD3293) is a highly potent and highly permeable, orally active BACE1 inhibitor (Ki: 0.4 nM) that crosses the blood-brain barrier, Lanabecestat can be used for the study of neurological diseases like Alzheimer's disease.
    • $149
    In Stock
    Size
    QTY
  • AZD3839 free base
    T67721227163-84-9
    AZD3839 free base is a potent and selective BACE1 inhibitor with Ki of 26.1 nM, about 14-fold selectivity over BACE2. Phase 1.
    • $48
    In Stock
    Size
    QTY
  • Epiberberine
    T5S23616873-09-2
    1. Epiberberine may be caused drug interactions based on CYP2D6 enzyme. 2. Epiberberine has anti-adipogenic effect is mediated by downregulation of the Raf/MEK1/ERK1/2 and AMPKα/Akt pathways during 3T3-L1 adipocyte differentiation. 3. Epiberberine, as the brightest FSA emitter among the alkaloids, can also serve as an efficient conformation probe for HTG DNA and discriminate the DNA G-quadruplex from the RNA counterpart.
    • $31
    In Stock
    Size
    QTY
  • Questin
    TN21313774-64-9
    Questin is an antimicrobial agent derived from Aspergillus florescens with an antimicrobial activity profile that inhibits V. harveyi, V. anguillarum, V. cholerae and V. parahemolyticus with MIC values of 31.25 µg/mL, 62.5 µg/mL, 62.5 µg/mL and 125 µg/mL, respectively. Questin has good potential to inhibit AChE, BChE and BACE1 and may be used in the development of drugs for the treatment or prevention of Alzheimer's disease.
    • $813
    Backorder
    Size
    QTY
  • LX2343
    T4398333745-53-2
    LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM. LX2343 acts as a non-ATP competitive PI3K inhibitor with an IC50 of 15.99±3.23 μM. LX2343 stimulates autophagy in its promotion of Aβ clearance.
    • $36
    In Stock
    Size
    QTY
  • Verubecestat
    T70111286770-55-5
    Verubecestat (MK-8931) (MK-8931) is an effective and specific β-secretase inhibitor and β-site APP-cleaving enzyme 1 inhibitor or BACE1 protein inhibitor.
    • $34
    In Stock
    Size
    QTY
  • Epiberberine chloride
    T8306889665-86-5
    Epiberberine chloride (Epiberberine (chloride)) is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor (IC50s: 1.07, 6.03 and 8.55 μM).
    • $54
    In Stock
    Size
    QTY
  • Auraptene
    T4115495-02-3
    Auraptene is a coumarin derived from citrus plants that bears a geranyloxyl moiety at its C-7. It has anti-inflammatory, anti-carcinogenic, anti-bacterial, neuroprotective, and hepatoprotective activities. It inhibits leukocyte activation and induces phas
    • $30
    In Stock
    Size
    QTY
  • LY2886721
    T60581262036-50-9
    LY2886721, a BACE inhibitor, is used for the therapy of Alzheimer's Disease.
    • $31
    In Stock
    Size
    QTY
  • 7-O-Methylaloeresin A
    TN1332329361-25-3
    7-O-Methylaloeresin A shows significant antioxidant activity, it also has moderate inhibitory active on BACE.
    • $290
    Backorder
    Size
    QTY
  • PF-06751979
    T124291818339-66-0
    PF-06751979 is an inhibitor of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) (IC50 of 7.3 nM in BACE1 binding assay).
    • $1,230
    Backorder
    Size
    QTY
  • BACE1-IN-5
    T104532581114-83-0
    BACE1-IN-5 (Compound 15), a potent β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, demonstrates significant efficacy with an IC50 of 9.1 nM for BACE1 inhibition and an impressive IC50 of 0.82 nM against cellular amyloid-β (Aβ) production. Additionally, it is engineered to enhance hERG inhibition and P-gp efflux, indicating its optimized medicinal chemistry profile [1].
    • $1,520
    Backorder
    Size
    QTY
  • BACE1-IN-4
    T104522361157-92-6
    BACE1-IN-4 is a potent and highly selective BACE1 inhibitor (IC50: 3.8 nM; Ki: 1.9 nM), more selective at BACE1 over BACE2.
    • $2,870
    Backorder
    Size
    QTY
  • LY2811376
    T26391194044-20-6
    LY2811376, an orally available non-peptidic β-secretase(BACE1) inhibitor (IC50: 239-249 nM), can decrease Aβ secretion (EC50: 300 nM). It has 10-fold selectivity towards BACE1 over BACE2, and more than 50-fold inhibition over other aspartic proteases including pepsin, cathepsin D, or renin.
    • $48
    In Stock
    Size
    QTY
  • Timosaponin BII
    T3394136656-07-0
    Timosaponin BII (Prototimosaponin A III) has anti-dementia activity and may be useful for the treatment of type 2 diabetes. Timosaponin BII has antioxidant activity, can inhibit the up-regulation of BACE1 and reduced the over-production of β-CTF and Aβ in rat retina, which was induced by FeCl .
    • $30
    In Stock
    Size
    QTY
  • Aloeresin D
    T8179105317-67-7
    Aloeresin D, a natural chromone glycoside, inhibits β-Secretase (BACE1) activity (IC50: 39 μM).
    • $81
    In Stock
    Size
    QTY
  • BACE1-IN-2
    T104511352416-78-4
    BACE1-IN-2 is a BACE1 inhibitor (IC50: 22 nM).
    • $2,570
    Backorder
    Size
    QTY
  • Umibecestat
    T132531387560-01-1
    Umibecestat is an inhibitor of beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1), with IC50s of 11 nM and 10 nM for human BACE-1 and mouse BACE-1, respectively. Umibecestat can be used for the research of alzheimer's disease.
    • $175
    In Stock
    Size
    QTY
  • 8-Geranyloxypsoralen
    TN13437437-55-0
    8-Geranyloxypsoralen inhibits α2-secretase (BACE1) activity in non-competitive manner, with the IC(50) values <25.0 μM, it can induce vasorelaxation on rat arterial tissues. 8-Geranyloxypsoralen possesses nematicidal activities, the median lethal concentrations (LC(50)) is 188.3 mg/ L against B. xylophilus and is 117.5 mg/L against P. redivivus.
    • $156
    In Stock
    Size
    QTY
  • Atabecestat
    T143381200493-78-2
    Atabecestat (JNJ-54861911) is an orally active and brain-permeable inhibitor of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) that slows cognitive decline in participants with preclinical Alzheimer's disease.Atabecestat is used in the study of Alzheimer's disease.
    • $132
    In Stock
    Size
    QTY
  • Loganin
    T275918524-94-2
    Loganin (Loganoside), an iridoid glucoside, has been reported to be an inhibitor of Cox-1 and also noted to suppress TNF-α formation. This compound also has displayed potent free-radical-scavenging activity and inhibitory effects on melanogenesis.
    • $40
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • NB-360
    T121881262857-73-7
    NB-360 is a potent and brain-penetrable inhibitor of BACE1 and BACE2 with IC50s of 5, 5, and 6 nM for mouse and human BACE1 and BACE2. NB-360 exhibits excellent selectivity over the related aspartyl proteases pepsin, cathepsin E, and cathepsin D.
    • $112
    In Stock
    Size
    QTY
  • Elenbecestat
    T111751388651-30-6
    Elenbecestat (E2609) is an effective oral bioutilization and CNS penetrating ACE-1 inhibitor for the treatment of Alzheimer's disease.
    • $64
    In Stock
    Size
    QTY